High expression of cereblon (CRBN) is associated with improved clinical response in patients with multiple myeloma treated with lenalidomide and dexamethasone

Daniel Heintel, Alberto Rocci, Heinz Ludwig*, Arnold Bolomsky, Simona Caltagirone, Martin Schreder, Sabine Pfeifer, Heinz Gisslinger, Niklas Zojer, Ulrich Jäger, Antonio Palumbo

*Corresponding author for this work

Research output: Journal article (peer-reviewed)Journal article

111 Citations (Scopus)

Fingerprint

Dive into the research topics of 'High expression of cereblon (CRBN) is associated with improved clinical response in patients with multiple myeloma treated with lenalidomide and dexamethasone'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Medicine and Dentistry